3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Graft vs Host Disease
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Cisplatin
53
Paclitaxel
27
Carboplatin
22
Brachytherapy
18
Radiotherapy
17
human papillomavirus vaccine, L1 type 16, 18
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Gemcitabine
12
Topotecan
8
Vaccines, Synthetic
7
Platinum
7
Papillomavirus Vaccines
7
Radiation
6
Bevacizumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
Neoadjuvant Therapy
5
Chemotherapy, Adjuvant
5
pembrolizumab
4
Vinorelbine
4
Radiotherapy, Intensity-Modulated
4
Pemetrexed
4
Drug Therapy
4
Taxes
3
Surgical Procedures, Operative
3
Ondansetron
3
Irinotecan
3
Dexamethasone
3
Chemoradiotherapy
3
tisotumab vedotin
2
specific substance maruyama
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Cervical Neoplasms
×
Proto-Oncogene Proteins c-raf
×
Clear all
NCT02957266
2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3
Unknown
400 enrolled